Vertex Pharmaceuticals Incorporated (VRTX) Q2 2008 Earnings Results

Vertex Pharmaceuticals Misses on Revenue, Stock Up 3.98%

Vertex Pharmaceuticals reported a wider-than-expected loss per share, but the stock rose nearly 4% after the announcement. This increase may reflect investor optimism despite the lack of revenue details and guidance. The positive EPS surprise suggests some underlying strength in the company's performance.

The print

Key numbers

Actual vs. consensus

Metric	Actual	Expected	Surprise
EPS	$-0.53	N/A	+14.52%
Revenue	N/A	N/A	N/A

Management

Management commentary

Tone: Unknown

No transcript is on record for this earnings call, and the analysis is based solely on the numerical results.

Vertex Pharmaceuticals Misses on Revenue, Stock Up 3.98%

Key numbers

Management commentary

Vertex Pharmaceuticals Incorporated

More earnings this week

Vertex Pharmaceuticals Misses on Revenue, Stock Up 3.98%

Key numbers

Management commentary